Tech Company Financing Transactions
GT Medical Technologies Funding Round
GT Medical Technologies, based in Tempe, secured $37 million from Accelmed, Evidity Health Capital and Gilde Healthcare Partners.
Transaction Overview
Company Name
Announced On
1/16/2025
Transaction Type
Venture Equity
Amount
$37,000,000
Round
Series D
Investors
Accelmed (Lead Investor)
Evidity Health Capital (Lead Investor)
MedTech Venture Partners (Radu Cautis)
Proceeds Purpose
The company intends to use the funds to accelerate the completion of the ROADS clinical study that is focused on GammaTile for newly diagnosed brain metastases, and the GESTALT clinical trial for patients with newly diagnosed glioblastomas (GBMs).
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1809 S Holbrook Ln.
Tempe, AZ 85281
USA
Tempe, AZ 85281
USA
Phone
Website
Email Address
Overview
Our purpose is to improve the lives of patients with brain tumors. We are focused on developing safe, effective, and cost-efficient treatments for tumors that cannot be entirely removed by surgery alone. Our first innovation GammaTile Therapy, is a surgically targeted radiation therapy for recurrent intracranial neoplasms.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Matthew Likens
Chief Technical Officer
David Brachman
VP - Bus. Development
Brian Martin
VP - Operations
Hernan Lopez
VP - Regulatory Affairs
Lisa Misell
VP - Sales
Craig Bushnell
Browse more venture capital transactions:
Prev: 1/16/2025: Adaptive Reader venture capital transaction
Next: 1/16/2025: Botika venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We record every notable VC transaction. VC transactions reported here are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs